Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Systemic Lupus Erythematosus Without Kidney Involvement: A Case Report

Paul Hoover, MD, PhD, & Lindsey MacFarlane, MD  |  Issue: September 2015  |  September 15, 2015

Figure 1: Hematoxylin & Eosin Staining

(Click for larger image)
Figure 1: Hematoxylin & Eosin Staining
Enlarged, hypercellular and lobular-appearing glomeruli; capillary loops are thickened and poorly defined (arrow). The mesangium is moderately expanded by extracellular matrix and increased numbers of mononuclear cells (star).

A 35-year-old female with a history of systemic lupus erythematosus (SLE) without kidney involvement was admitted to our hospital with low-grade fevers, headache, increasing lower extremity edema and elevated blood pressure.

History

She was first diagnosed with SLE as a teenager when she developed oral ulcers and pleuritic chest pain and tested positive for anti-Smith and anti-nuclear antibodies (ANAs), meeting four of 11 ACR criteria for SLE. As an adult, her SLE recurred every few years, manifesting as oral ulcers, alopecia, arthritis, biopsy-proven leukocytoclastic vasculitis (LCV) over her lower extremities and hypocomplementemia. She had no prior episodes of nephritis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Until two months prior to presentation, her symptoms were well controlled with hydroxychloroquine, mycophenolate mofetil (MMF) and low-dose prednisone. However, while transitioning between rheumatologists, she stopped her medications and developed her usual SLE symptoms, including oral ulcers, arthritis and lower extremity rash. In addition, she reported low-grade fevers, headaches, fatigue, pleuritic chest pain, dyspnea on exertion, six-pillow orthopnea and pitting edema in her lower extremities. A physician family member prescribed 60 mg of prednisone daily. Her breathing and chest pain improved, but she continued to experience headaches and recorded her own blood pressures, which reached systolic blood pressure of 225 mmHg.

Her new rheumatologist found hypocomplementemia and proteinuria, hydroxychloroquine was resumed, MMF changed to azathioprine, and lisinopril was prescribed. Over the next several weeks, her symptoms improved, but hypocomplementemia and proteinuria continued. Her nephrologist scheduled an elective kidney biopsy, but prior to her biopsy low-grade fevers, headache, pitting edema and hypertension recurred. She sought emergency care resulting in admission to our institution.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Hospital Assessment

On initial assessment, she was afebrile with a blood pressure of 170/90 mmHg, breathing comfortably with an oxygen saturation of 97% on room air. She was in no distress and had moderate periorbital edema. Her lungs were clear to auscultation. Examination of her lower extremities revealed synovitis in her left ankle and bilateral lower extremity pitting edema with an overlying palpable purpuric rash with a few shallow ulcers.

Her basic metabolic profile was within normal limits and included a BUN of 22 mg/dL and creatinine of 0.83 mg/dL. Her complete blood cell count was remarkable for a low, but stable hematocrit at 27% (lower limit of normal 36%). ESR and CRP were elevated at 27 mm/hr and 4.4 mg/L, respectively. Serologies yielded a positive ANA at 1:640 (speckled), while the remainder of the extractable nuclear and double-stranded DNA autoantibodies was negative. Complement levels were low, with C3 at 52 and C4 at 2 mg/dL, respectively (normal C3 90–180, C4 10–40 mg/dL). Her urine contained 3+ blood, 3+ protein and hyaline casts. The spot urine protein to creatinine ratio was 328:51, suggesting 6.4 g of urinary protein excretion over 24 hours. Antiphospholipid antibodies were negative, while ANCA and cryoglobulins were pending.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:ClinicalDiagnosiskidneyoutcomepatient careSLEstemic lupus erythematosus

Related Articles

    Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

    February 16, 2021

    Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

    Figure 2: Renal Biopsy

    The Classification & Diagnosis of Granulomatosis with Polyangiitis

    August 16, 2018

    Based on the classification system developed by the Chapel Hill Consensus Conference, anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is defined as a necrotizing vasculitis involving small vessels that is associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA and displays minimal immune deposits. The mechanism behind the pathogenesis of ANCA-associated vasculitis is not fully…

    ACR Winter Rheumatology Symposium: Tips for ANCA Testing

    May 1, 2013

    How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests

    Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

    Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

    June 21, 2018

    Granulomatosis with polyangiitis (GPA) was first described in the British Medical Journal in 1897 by Scottish otolaryngologist Peter McBride.1 GPA is a relatively rare, systemic necrotizing vasculitis that can make diagnosis challenging. The incidence has been estimated anywhere between two and 12 cases per million.2 GPA mainly affects adults between the ages of 45 and…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences